In large doses, lysergic acid diethylamide (LSD) can repair damaged neurons in the brain, and reveal new ways of seeing the world. In small doses, microdosers chase the effects of the drug on ...

An LSD-like drug could treat depression in humans without sending patients on a Magical Mystery Tour, according to a new scientific study. Scientists had culled the new drug from a library of 75 ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

A recent study by MindMed reveals that LSD could be a potential treatment for anxiety. A single dose significantly reduced anxiety symptoms in individuals with generalized anxiety disorder, with ...

A little bit of hallucinogen can go a long way in alleviating physical pain. New research has found that a microdose of lysergic acid diethylamide (LSD) significantly increases human pain tolerance ...

A recent study published in the British Journal of Pharmacology looked into how psychedelics like LSD can affect the biological endocannabinoid system, otherwise targeted by cannabis compounds, which ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

Among psychedelic enthusiasts, April 19 or Bicycle Day honors a mind-altering ride taken by the Swiss chemist who created LSD. Bicycle Day marks a hallucinogenic ride that's considered the birth of ...

A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...

NEW YORK, May 26, 2021 /CNW/ — MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first pharmacogenetic data on LSD to ...